Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-16-005019
Accepted
2016-06-29 00:15:12
Documents
1
Effectiveness Date
2016-06-28
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-16-005019.txt   1694
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-212095 | Film No.: 161737241
SIC: 2834 Pharmaceutical Preparations